Recursion Patents

Patent portfolio assigned to Recursion (verified via public assignee records). Recursion Pharmaceuticals (AI/phenomics drug discovery; merged with Exscientia in 2024). Multiple patents assigned to Recursion Pharmaceuticals, Inc. on Google Patents/Justia. No customer list (drug developer / pharma partnerships rather than named buyers).